VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 386.05 EUR -0.49% Market Closed

Market Cap: €99.7B

V	Vertex Pharmaceuticals Inc F:VX1	US
C	Citigroup Inc SGO:C	US
C	Cdon AB STO:CDON	SE
	StarHub Ltd SGX:CC3	SG
	Aqua Metals Inc NASDAQ:AQMS	US
	Robinhood Markets Inc NASDAQ:HOOD	US
C	COMPUTERSHARE LIMITED XBER:QCH	AU
	Gear Energy Ltd TSX:GXE	CA
	Brightstar Resources Ltd ASX:BTR	AU
C	Chocoladefabriken Lindt & Spruengli AG DUS:LSPN	CH
N	New Stratus Energy Inc XTSX:NSE	CA

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

42% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

50% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.